Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 3 , Pages 227-230 , September 2009

Photodynamic therapy adjuvant to surgery in metastatic carcinoma in brain

References 

  1. Klos KJ, O’Neill BP. Brain metastases. Neurologist. 2004;10:31–46
  2. Chang EL, Wefel JS, Maor MH, et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery. 2007;60:277–283(discussion 283–284)
  3. Mehta MP, Rodrigus P, Terhaard CH, et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Glin Oncol. 2003;21:2529–2536
  4. Guillamo JS, Emery E, Busson A, Lechapt-Zalcman E, Constans JM, Defer GL. Current management of brain metastases. Rev Neurol (Paris). 2008;164:560–568
  5. Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist. 2007;12:884–898
  6. Eljamel MS. Brain photodiagnosis (PD), fluorescence guided resection (FGR) and photodynamic therapy (PDT): past, present and future. Photodiagn Photodyn Ther. 2008;5:29–35
  7. Eljamel MS, Goodman C, Moseley H. ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers Med Sci. 2008;23:561–567
  8. Krishnamurthy S, Powers SK, Witmer P, Brown T. Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors. Lasers Surg Med. 2000;27:224–234
  9. Muller PJ, Wilson BC. Photodynamic therapy for recurrent supratentorial gliomas. Semin Surg Oncol. 1995;11:346–354
  10. Kostron H, Fritsch E, Grunert V. Photodynamic therapy of malignant brain tumors; a phase I/II trial. Br J Neurosurg. 1988;2:241–248
  11. Powers SK, Cush SS, Walstad DL, Kwock L. Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. Neurosurgery. 1991;29:688–695
  12. Stummer W, Stepp H, Moller G, et al. Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir. 1998;140:995–1000
  13. Stummer W, Stocker S, Wagner S, et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid induced porphyrin fluorescence. Neurosurgery. 1998;42:518–525
  14. Marks PV, Belchetz PE, Saxena A, et al. Effect of photodynamic therapy on recurrent pituitary adenomas clinical phase I/II trial—an early report. Br J Neurosurg. 2000;14:317–325
  15. Stummer W, Oitchimeier U, Meinel T, Wiestler OD, Zanella F, Reulen H. Fluorescence-guided surgery with 5-aminolevulininc acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol. 2006;7:392–401
  16. Lohr F, Pirzkall A, Hof H, Fleckenstien K, Debus J. Adjuvant treatment of brain metastases. Semin Surg Oncol. 2001;20:50–56
  17. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322:494–500
  18. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol. 1993;33:583–590
  19. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. JAMA. 2006;295:2483–2491

PII: S1572-1000(09)00132-X

doi: 10.1016/j.pdpdt.2009.09.003

Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 3 , Pages 227-230 , September 2009

Article Tools

* Image Usage & Resolution